Presentations & Posters

Profiling bispecific T-cell engagers: Strategies for enhancing potency while minimizing cytokine release

Diverse CD28-binding antibodies for costimulatory T-cell engager development

Development of PSMA x CD3 T-cell engagers using an integrated, functional approach

Target-dependent considerations for the design of bispecific T-cell engagers

Functional and specific T-cell engagers for a peptide-MHC tumor target

A rational approach for selecting CD3-binding antibodies for T-cell engager development

August 27, 2024

Developability considerations for bispecific and multispecific antibodies

February 14, 2023

Potent transmission-blocking monoclonal antibodies from naturally exposed individuals target a conserved epitope on Plasmodium falciparum Pfs230

February 14, 2023

Highly potent, naturally acquired human monoclonal antibodies against Pfs48/45 block Plasmodium falciparum transmission to mosquitoes

Scientific Case Studies

Designing T-cell engagers to widen the therapeutic window

Functional and specific T-cell engagers for a peptide-MHC tumor target

Discovery of diverse GPCR-targeted antibodies

Diverse CD28-binding antibodies for costimulatory T-cell engager development

Development of PSMA x CD3 T-cell engagers using an integrated, functional approach

Antibody candidates ready for IND-enabling studies